Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001474212 | SCV000726984 | likely benign | not provided | 2020-06-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000709209 | SCV000838638 | benign | Hereditary cancer-predisposing syndrome | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001474212 | SCV001678380 | likely benign | not provided | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001474212 | SCV002047076 | benign | not provided | 2021-05-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000709209 | SCV002659819 | likely benign | Hereditary cancer-predisposing syndrome | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003962815 | SCV004780942 | likely benign | RECQL-related condition | 2022-03-18 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |